Alessandra Fusco, Sara Colarusso, Marco Piscopo, Maria Rosaria Improta, and Marco Corigliano. 2017. “Short-Term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience”. Heart Research 4 (3):46-56. https://doi.org/10.17140/HROJ-4-141.